Evicenter
P&T meetings

Tirabrutinib

Primary central nervous system lymphoma

Regulatory submission
NDA submitted December 2025
Last updated
72 sources

Product information and disease descriptionProduct descriptionProduct information

Product comparison

2 evidence topics · 4 sources

Meta-analysis of tirabrutinib monotherapy across B-cell malignancies

“seven clinical trials involving a total of 301 patients with CLL, PCNSL, MCL, and WM” (opens the source at this quote in a new tab)

Meta-analysis including tirabrutinib treatment regimens

“Only two studies including 188 patients evaluated tirabrutinib-based treatment regimens” (opens the source at this quote in a new tab)